ALEMBICLTDUpdated 5 Sept 2026, 2:16

Alembic Limited

ALEMBICLTDUpdated 5 Sept 2026, 2:16

Market Cap

₹2,862Cr.

Current Price

₹111

High / Low

₹118/70.5

Stock P/E

23.4

ROE14.2%

ROCE16.9%

Book Value₹32.0

Face Value₹2.00

Dividend Yield2.15%

About

Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.With its registered office in Vadodra, Alembic Ltd currently holds a 28.41% stake in Alembic Pharma Ltd and a 19.01% stake in another group entity Paushak Limited.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	122	76	54	74	40	44	66	72	67	42	47	48
Inventory Days	880	659	438	247	289	411	2,112	2,885	5,118	3,694	—	1,161
Days Payable	200	144	128	125	202	151	675	635	993	1,213	—	510
Cash Conversion Cycle	801	591	364	195	126	304	1,504	2,322	4,191	2,523	47	698
Working Capital Days	235	172	39	20	13	28	96	231	127	75	58	-2
ROCE %	9%	8%	8%	10%	10%	21%	2%	10%	10%	12%	18%	17%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 5 September 2026 at 2:16

ALEMBIC LIMITED (ALEMBICLTD) financials — quarterly results, P&L, cash flow, balance sheet, shareholding